Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-May 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5025388015 | Soybean oil refined 200 mg/mL emulsion for infusion and/or injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5073139011 | Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5073140013 | Soya bean oil refined 200 mg/mL emulsion for infusion and/or injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Is a | Product containing only Glycine max oil refined in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Has manufactured dose form | Conventional release emulsion for infusion and/or injection (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Has precise active ingredient | Soya bean oil refined | true | Inferred relationship | Some | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Has basis of strength substance (attribute) | Soya bean oil refined | true | Inferred relationship | Some | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Is a | True | Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Inferred relationship | Some | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for injection (clinical drug) | Is a | True | Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR